Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Early experience with a universal (DDD) pacing device.

D L Hayes, D R Holmes, R E Vlietstra

    Mayo Clinic Proceedings
    |May 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.

    Heart (British Cardiac Society)·2007
    Same author

    Non-paroxysmal junctional tachycardia with type I exit block.

    Heart (British Cardiac Society)·2002
    Same author

    Triboelectric simulation of pacemaker malfunction.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2002
    Same author

    Radiofrequency treatment of hepatic neoplasms in patients with permanent pacemakers.

    Mayo Clinic proceedings·2001
    Same author

    Breath-holding spells associated with significant bradycardia: successful treatment with permanent pacemaker implantation.

    Pediatrics·2001
    Same author

    Left ventricular and biventricular pacing in congestive heart failure.

    Mayo Clinic proceedings·2001
    Same journal

    Thyroid Dysfunction and the Risk of Clinically Relevant Depression: A Longitudinal Cohort Study.

    Mayo Clinic proceedings·2026
    Same journal

    37-Year-Old Woman With Jaundice.

    Mayo Clinic proceedings·2026
    Same journal

    34-Year-Old Woman With An Unidentified Overdose.

    Mayo Clinic proceedings·2026
    Same journal

    Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

    Mayo Clinic proceedings·2026
    Same journal

    Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

    Mayo Clinic proceedings·2026
    Same journal

    RAAS Inhibition in the ICU: Stop, Continue, or Restart?

    Mayo Clinic proceedings·2026
    See all related articles

    This study evaluated the new universal DDD pacemaker in 38 patients. Pacemaker-mediated tachycardia occurred in six patients but was successfully treated by reprogramming the dual-chamber pacing mode.

    Area of Science:

    • Cardiology
    • Biomedical Engineering

    Background:

    • Dual-chamber pacemakers are crucial for maintaining atrioventricular synchrony.
    • The pacemaker syndrome can occur with single-chamber pacing.
    • Advancements in pacemaker technology aim to improve patient outcomes and reduce complications.

    Purpose of the Study:

    • To assess the advantages and complications of the new universal DDD pacemaker.
    • To evaluate the safety and efficacy of DDD pacing in a patient cohort.
    • To identify common issues and effective management strategies for DDD pacemaker use.

    Main Methods:

    • Retrospective study of 38 patients receiving a new universal DDD pacemaker.
    • Analysis of patient demographics, indications for pacing, and follow-up data.
    • Evaluation of pacemaker mode changes and reprogramming interventions.

    Related Experiment Videos

    Main Results:

    • Pacemaker-mediated tachycardia (PMT) developed in six patients, successfully treated by reprogramming.
    • Seven patients experienced sensing issues (loss of capture/undersensing), primarily atrial undersensing.
    • Noninvasive reprogramming effectively resolved sensing problems in most cases.

    Conclusions:

    • The DDD pacemaker offers benefits for patients requiring atrioventricular synchrony or with a history of pacemaker syndrome.
    • Pacemaker-mediated tachycardia is a notable complication, preventable by pre-implantation assessment of ventriculoatrial conduction.
    • Reprogramming is an effective strategy for managing DDD pacemaker complications.